Navigation Links
Immunotherapy in Medical News

Johnson & Johnson and Elan Corporation plc Announce Definitive Agreement for Alzheimer's Immunotherapy Program and Equity Investment

NEW BRUNSWICK, N.J. and DUBLIN, July 2 /PRNewswire-FirstCall/ -- Johnson & Johnson (NYSE: JNJ ) and Elan Corporation plc (NYSE: ELN ) today announced a definitive agreement whereby Johnson & Johnson will acquire substantially all of the assets and rights of Elan related to its Alzheime...

Sublingual immunotherapy for inhalant allergies deserves deeper consideration

Alexandria, VA Sublingual immunotherapy for the treatment of allergy symptoms caused by a wide variety of environmental inhalants has been effectively used in Europe. It should be employed to further treatment of allergies in the United States, where allergic symptoms are largely undertreated, ac...

Prostate cancer immunotherapy significantly prolongs survival in men with advanced prostate cancer

CHICAGO, ILSipuleucel-T (Provenge), an experimental immunotherapy improved survival in men with metastatic disease, according to new results to be presented April 28 at the American Urological Association (AUA) Annual Scientific Meeting in Chicago. These data from the Phase 3 Immunotherapy for Pro...

A new light on tumor immunotherapy for gastric cancer

Dendritic cells (DCs) are professional antigen presenting cells (APCs) that both initiate and modulate the immune response. DCs are cells in the pathway of antigen capture and presentation to T cells, with the unique ability to directly prime nave CD4+ and CD8+ T cells. Gastric cancer is one of th...

33rd Annual Hutch Holiday Gala Raises Millions for Cancer Immunotherapy Research

SEATTLE, Dec. 8 /PRNewswire/ -- Saturday's Hutch Holiday Gala raised more than $2.2 million for cancer and related disease research at Fred Hutchinson Cancer Research Center. "Help the Hutch," a portion of the live auction during which guests raise their bid cards for specific contribution...

MaxCyte to Present Targeted Cancer Immunotherapy Product at 50th Annual Meeting of the American Society of Hematology

'A Highly Efficient, Clinical Method to Redirect the Specificity of Immune Cells and Enhance Their Anti-Tumor Capacity' GAITHERSBURG, Md., Dec. 4 /PRNewswire/ -- MaxCyte, Inc., a clinical-stage therapeutics company and pioneer in clinical scale, non-viral cell loading systems, announces ...

OHSU Cancer Institute researcher: radiation, immunotherapy gives greater effectiveness

PORTLAND, Ore. Oregon Health & Science University Cancer Institute researchers have found the right formula of radiation and immunotherapy for fighting lung cancer tumors in mice, which they hope will translate to better treatment in human lung cancers. The study was presented today at the 50...

Latest research on allergies: Specific immunotherapy can help

The German Institute for Quality and Efficiency in Health Care has assessed recent evidence on allergies. It found that the once controversial immune therapy against allergy symptoms can definitely help many people with allergies. When it is green and the flowers have returned, the allergy seas...

Dangerous Side Effect Found in Cancer Immunotherapy Research

Lab experiment resulted in T-cells spreading beyond treatment area TUESDAY, June 3 (HealthDay News) -- When scientists first began looking into using the body's own immune system to target malignancies, it was hoped that the therapy would be able to zero in on a specific cancer withou...

Oral Allergy Immunotherapy Helps Control Asthma

Drops or tablets avoid the pain and side effects of shots, review finds TUESDAY, March 4 (HealthDay News) -- Oral allergy immunotherapy -- in the form of drops or tablets -- is effective at reducing asthma symptoms and the need for asthma medications in children who have what's known a...

More>>

Immunotherapy in Medical Technology

Prostate Cancer Immunotherapy Significantly Prolongs Survival in Men With Advanced Prostate Cancer

Phase 3 IMPACT Trial Results to be presented during late-breaking session at AUA Annual Scientific Meeting CHICAGO, April 28 /PRNewswire-USNewswire/ -- Sipuleucel-T (Provenge), an experimental immunotherapy improved survival in men with metastatic disease, according to new results to be pr...

Karmanos Cancer Institute Researchers Show Phase I Immunotherapy with Armed T Cells Improve Overall Survival of Metastatic Breast Cancer Patients

CHICAGO, June 1 /PRNewswire/ -- Researchers at the Barbara Ann Karmanos Cancer Institute in Detroit today presented findings that show immunotherapy with armed targeted T cells may improve the overall survival of women with metastatic breast cancer. (Logo: http://www.newscom.com/cgi-bin/p...

New Data on MAGE-A3 Cancer Immunotherapy Support Potential Novel Options of Treating Non-Small Cell Lung Cancer and Melanoma

Gene Expression Profiling of Tumor is Correlated With Clinical Response CHICAGO, May 30 /PRNewswire-FirstCall/ -- New data presented by GlaxoSmithKline (GSK) today highlighted the potential of its investigational MAGE-A3 Antigen-Specific Cancer Immunotherapeutic (ASCI) through results of three...

Cell Genesys Reports Association Between Immune Response and Patient Survival in Phase 2 Trial of GVAX Immunotherapy for Prostate Cancer

SOUTH SAN FRANCISCO, Calif., Feb. 15 /PRNewswire-FirstCall/ -- Cell Genesys, Inc. (Nasdaq: CEGE ) today reports the results of an analysis examining the potential association between immune responses to GVAX immunotherapy for prostate cancer and increased patient survival in a Phase 2 trial i...

Interim Analysis Supports Continuation of Cell Genesys' VITAL-1 Phase 3 Clinical Trial of GVAX Immunotherapy for Prostate Cancer

Conference Call Scheduled for 10:00 a.m. ET Today SOUTH SAN FRANCISCO, Calif., Jan. 14 /PRNewswire-FirstCall/ -- Cell Genesys, Inc. (Nasdaq: CEGE ) today announced that the Independent Data Monitoring Committee (IDMC) for VITAL-1, the first of two ongoing Phase 3 clinical trials of...

Cell Genesys Provides Final Median Survival Data From Second Phase 2 Trial of GVAX Immunotherapy for Prostate Cancer

SOUTH SAN FRANCISCO, Calif., April 03, 2007 /PRNewswire-FirstCall/ -- Cell Genesys, Inc. today announced final, updated results from its second multi-center Phase 2 trial of GVAX immunotherapy for prostate cancer which evaluated escalating doses of the immunotherapy in 80 patients with metastatic ...

Cell Genesys Reports GVAX Immunotherapy for Prostate Cancer Induces a Broad, Patient-Specific Antibody Response

SOUTH SAN FRANCISCO, Calif., April 17, 2007 /PRNewswire-FirstCall/ -- Cell Genesys, Inc. today reported immune response data from two previously conducted Phase 2 clinical trials of GVAX immunotherapy for prostate cancer. Evaluation of antibody responses in patients with advanced prostate cancer f...

Favrille Announces Results From Study Showing Enhanced Activity From Insect Cell-Derived Immunotherapy for Lymphoma

Data Reported at American Association for Cancer Research Annual Meeting SAN DIEGO, April 18, 2007 /PRNewswire-FirstCall/ -- Favrille, Inc. , a biopharmaceutical company developing patient-specific, active immunotherapies for the treatment of cancer, announced results from a new study showing enha...

Cell Genesys Reports Additional Data From Phase 2 Clinical Trial of GVAX Immunotherapy for Pancreatic Cancer

SOUTH SAN FRANCISCO, Calif., June 04, 2007 /PRNewswire-FirstCall/ -- Cell Genesys, Inc. today announced follow-up data from a Phase 2 clinical trial of GVAX immunotherapy for pancreatic cancer which was conducted by the Johns Hopkins Sidney Kimmel Cancer Center. The trial enrolled 60 patients with...

CEL-SCI to Present Data from Multikine Clinical Trials at National Institutes of Health (NIH), National Cancer Institute (NCI) Seminar Series

...ration (NYSE Amex: CVM ), a late stage cancer immunotherapy company, announced today that Dr. Eyal Talor, CE...is: "Multikine: Cancer Immunotherapy; how to make immunotherapy for cancer work" . In the presentation, Dr. Talor will discuss Multikine's immunotherapy clinical program for cancer, the unique mechanism ...

More>>

Immunotherapy in Medical Definition

Medical procedure

...ump Politzerization Hemodialysis Hemofiltration Plasmapheresis Apheresis Extracorporeal membrane oxygenation (ECMO) Cancer immunotherapy Cancer vaccine Cervical conization Chemotherapy Cytoluminescent therapy Insulin potentiation therapy Low-dose chemotherapy ...

Pathology

... osteosarcoma - Chondroma / chondrosarcoma - Glioma - Lymphoma / leukemia Treatment Surgery - Chemotherapy - Radiation therapy - immunotherapy - Experimental cancer treatment Misc. Tumor suppressor genes / oncogenes - Staging / grading - Carcinogenesis - Carcinogen - Resea...

Ocular oncology

... osteosarcoma - Chondroma / chondrosarcoma - Glioma - Lymphoma / leukemia Treatment Surgery - Chemotherapy - Radiation therapy - immunotherapy - Experimental cancer treatment Misc. Tumor suppressor genes / oncogenes - Staging / grading - Carcinogenesis - Carcinogen - Resea...
Immunotherapy in Medical Dictionary

Slit

...taples, fast and free delivery on most orders of $50 or more. Low prices on office essentials. Staples that was easy. Talking Points on Sublingual immunotherapy ( SLIT ) ... is the effective SLIT dosing range? In a comprehensive review of SLIT studies published through October ... Shop for Slit Train...

Intradermal

...for headache and Migraine ... There were two reasons for choosing intradermal Botox: ... Allergy testing, including intradermal testing, and immunotherapy (hyposensitization) in dogs. ... Intradermal skin testing is the gold standard of allergy ... Intradermal injections are injections given ...

Hyposensitization

...her animal health professionals as a concise and ... Hyposensitization or immunotherapy ... hyposensitization A method of reducing sensitivity to an allergen...posensitizing ... Allergy testing, including intradermal testing, and immunotherapy ( hyposensitization ) in dogs. ... The hyposensitization injections have ...

Bladder Cancer

...it ... a major risk factor for developing bladder cancer . ... Smoking increases the risk of developing bladder cancer nearly fivefold. ... immunotherapy for bladder cancer is usually performed using the Bacille Calmette ... Fox Chase Cancer Center's team of physicians offer the newest treatm...

Allergen

...ity reaction in atopic individuals. Allergen immunotherapy is a form of immunotherapy for allergic disorders in which the patient is vac...uding Botox, Alphagan, and Refresh. Allergen immunotherapy is a form of treatment aimed at decreasing your ...
Immunotherapy in Biological News

Cancer immunotherapy shows long-term promise in lung cancer

New, long-term results from a clinical trial presented today at the 1st European Lung Cancer Conference jointly organized by the European Society for Medical Oncology (ESMO) and the International Association of the Study of Lung Cancer (IASLC) show that MAGE-A3 ASCI (Antigen-Specific Cancer Immuno...

NCI Researchers Confirm the Effectiveness of Immunotherapy Approach to Treating Melanoma

A team of researchers, led by Steven A. Rosenberg, M.D., at the National Cancer Institute, part of the National Institutes of Health, have found that patients with advanced melanoma who had not responded to previous therapies experienced a significant reduction in the size of their cancers as a res...

$20 million NIH grant to transform clinical research at UIC

... Some projects already funded by the center include developing a collaborative research program in asthma and allergic diseases, exploring a promising immunotherapy to treat severe infections in patients with compromised immune systems, and a multi-disciplinary approach to improving cancer care for rural residents...

Alzheimer's, asthma, cancer, malaria and TB focus of new Singapore grants

...lo t 5. "Immunotherapy remains the only truly disease-modifying treatment for asthma and allergic rhinitis," said Dr. Chua. "Traditional forms of immunotherapy use natural sources of allergens and have numerous disadvantages, such as the presence of undefined material, huge variability in sample composition, ...

Novel lung cancer vaccine shows promise in fighting early-stage lung cancer

...s at the beginning of treatment and then eight injections every three months later for a total of 27 months. Earlier phases of the study indicate the immunotherapy treatment was well tolerated by patients. ...

Engineers create intelligent molecules that seek-and-destroy diseased cells

...s in breast, prostate and brain cancers, including immunotherapy applications based on reprogramming human immune r...Cancer Center in Duarte, Calif.) that have ongoing immunotherapy trials for treating glioma, a severe type of brain...er implications for using intelligent molecules in immunotherapy and gene therapy seem limitless. Researchers and d...

Molecule that suppresses immune response under study in type 1 diabetes

...-producing cells of the pancreas. "We want to create a no-go zone," said Dr. Andrew Mellor, immunologist who directs the Medical College of Georgia immunotherapy Center. Type 1 diabetes is classified as an autoimmune disease because the immune system targets healthy islet cells for destruction, leaving young pa...

DNA component can stimulate and suppress the immune response

...iscovered IDO's immunosuppressive capabilities more than a decade ago. With the help of Drs. Babak Baban and Phillip Chandler, scientists in MCG's immunotherapy Center, they've also learned IDO inhibits inflammation by blocking production of interleukin 6, a secreted factor that causes inflammation. "This s...

Children's National researchers develop novel anti-tumor vaccine

...ing significant impact on tumor growth in mice, according to new research published in the October edition of the research journal Cancer Immunology, immunotherapy . The vaccine uses the tumor's own protein to induce an immune system response, allowing for a personalized approach to treatment. The vaccine and...

Immunotherapy in high-risk pediatric sarcomas shows promising response

...e National Institutes of Health (NIH) believe that immunotherapy could prove beneficial in treating high-risk forms...tudy. The 22 enrolled patients who did not receive immunotherapy had a 31 percent five-year overall survival, compa...tatic or recurrent disease. This study shows that immunotherapy is safe and well tolerated, and could ultimately b...
Immunotherapy in Biological Technology

Pre-Clinical Data on CEA-specific BiTE Antibody Published in Journal of Immunotherapy Demonstrate Potent Control of Tumor Growth

BETHESDA, Md., April 8 /PRNewswire-FirstCall/ -- Micromet, Inc. (Nasdaq: MITI ), a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today announced the publication of data in the peer-reviewed Journal of Immunot...

Quest PharmaTech Announces Results Showing its Photosensitizer, SL052, is an Effective Immuno-Stimulant when combined with Immunotherapy for the Removal of Solid Tumors

TSX Venture: QPT EDMONTON, March 4 /PRNewswire-FirstCall/ - Quest PharmaTech Inc. (TSX-V: QPT), ("Quest" or the "Company") a pharmaceutical company developing and commercializing products for the treatment of cancer and dermatological conditions, today announced results from a study designed ...

Vasogen to Present at the BIO CEO & Investor Conference and Participate on the Non-Cancer Immunotherapy Panel

MISSISSAUGA, ON, Feb. 5 /PRNewswire-FirstCall/ - Vasogen Inc. (NASDAQ: VSGN ; TSX:VAS), a biotechnology Company focused on the research and commercial development of technologies targeting the chronic inflammation underlying cardiovascular and neurological disease, today announced that Chris W...

Binex and MaxCyte Collaborate on Cancer Immunotherapy Research

BUSAN, South Korea and GAITHERSBURG, Md., Nov. 30 /PRNewswire/ -- Binex (KOSDAQ: 053030) and MaxCyte, Inc. announced today the signing of a Sponsored Research Agreement to evaluate MaxCyte's GMP-compliant cell loading technology for use in closed-system manufacturing of Binex's cell-based canc...

Medinet Licenses MaxCyte Cell Loading Technology for Cancer Immunotherapy in Japan

GAITHERSBURG, Md. and YOKOHAMA, Japan, Aug. 27 /PRNewswire/ -- MaxCyte, Inc. and Medinet Co., Ltd. (TSE: #2370) announced today the signing of an exclusive license, development and supply agreement to use MaxCyte's proprietary cell loading system to support clinical studies and commercializati...

Lytix Biopharma and KAEL-GemVax Announce Joint Clinical Trial to Combine LTX-315 and GV1001 Cancer Immunotherapy

TROMS0, Norway and SEOUL, Korea, June 19 /PRNewswire/ -- The Norwegian biopharmaceutical company Lytix Biopharma and Korean company KAEL-GemVax today announced the signing of a collaborative agreement to test lead compounds LTX-315 and GV1001 as a combination therapy for the treatment of cance...

Dendreon to Hold Conference Call on Tuesday, August 11, 2009 at 11:30 AM ET

...ization of novel therapeutics. The Company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy product candidates designed to stimulate an immune response. Dendreon is also developing an orally-available small molecule that targets TRPM8 that c...

Northwest Biotherapeutics Announces Plans to De-list From AIM and Consolidate its Stock Market Listing in U.S.

...tion and operations. About Northwest Biotherapeutics Northwest Biotherapeutics is a biotechnology company focused on developing immunotherapy products that treat cancers more effectively than current treatments, without toxicity, on a cost-effective basis. The Company has two broad platform...

NewLink Genetics Corporation Closes $7.5 Million Financing

...nk, Chairman and Chief Executive Officer of NewLink Genetics Corporation. "The proceeds of this financing will allow us to both rapidly move our lead immunotherapy product for pancreatic cancer into pivotal clinical studies and to advance our IDO inhibitor, D-1MT, into multiple Phase 2 studies." About Ne...

Studies Presented at International Conference on Alzheimer's Disease Reveal Substantial Economic Costs and Caregiver Burden Associated with Alzheimer's Disease

... of Elan. "Elan and Wyeth, through the Alzheimer's immunotherapy Program (AIP), are committed to advancing research...f work is important and we applaud the Alzheimer's immunotherapy Program (AIP) for supporting research to better un...Elan and Wyeth Collaboration The Alzheimer's immunotherapy Program (AIP) is a collaboration between Elan and ...
Immunotherapy in Biological Definition

Immune system

... autoimmune disorders CD4 receptor /CD8 receptor / perforin / apoptosis /clonal selection immunosuppression immunosuppressive drug immunotherapy lymphatic system / lymphocyte macrophage major histocompatibility complex / class I MHC /class II MHC monoclonal antibody / polycl...

Immunology

...sical immunology 3 Clinical immunology 4 immunotherapy 5 Diagnostic immunology 6 Evolutionary i...mpts to destroy allografts or xenografts . immunotherapy See main article immunotherapy The use of immune system components to treat a...
Immunotherapy in Biological Dictionary

Dendritic cell

... in antigen presentation and are thought to be more ... What Is a Dendritic Cell ? Dendritic cells (DC), derived from bone marrow, are ... immunotherapy not based on dendritic cells is also being developed, such as ... Playing the dendritic cell maturational scale, to create different therap...
Other Tags
(Date:8/1/2015)... ... , ... On March 19, 2015 Phil Valentine – the Executive Director of Connecticut Community for ... by stepping off Springer Mountain and heading north. Since that day, Phil has hiked over ... was greeted by friends and family. He visited CCAR and left an inspirational message ...
(Date:7/31/2015)... ... August 01, 2015 , ... Super Bowl 50 will emanate from Levi’s Stadium in ... each year is the Super Bowl. In the two weeks that separate the conference championships ... venue. The 2016 Super Bowl game will mark the 50th time it has been held ...
(Date:7/31/2015)... ... July 31, 2015 , ... The 2nd annual Ride to Fight On ... on October 3, 2015. The Ride to Fight On is a cycling fundraiser that ... Healthcare, The West Clinic and The University of Tennessee Health Science Center. A health ...
(Date:7/31/2015)... , ... July 31, 2015 , ... Coco Libre announced ... judges, media, and VIPs at the 2015 Vans US Open of Surfing, July 25 ... that can claim “no added sugar” on the market, is a natural choice given ...
(Date:7/31/2015)... ... July 31, 2015 , ... Well-known for its unique ... wedding cakes with custom designs, making life just a little bit sweeter ... wedding cakes for each customer who orders one. , The bakery provides a full ...
Breaking Medicine News(10 mins):Health News:Connecticut Executive Hikes Appalachian Trail to Raise Awareness About Recovery. 2Health News:Cheap 2016 Super Bowl Tickets at Levi's Stadium: Ticket Down Slashes Ticket Prices on Super Bowl 50 Tickets in Santa Clara, CA at Levi's Stadium 2Health News:West Cancer Center Announces 2nd Annual Ride to Fight On 2Health News:West Cancer Center Announces 2nd Annual Ride to Fight On 3Health News:Coco Libre Brings Eco-conscious Hydration to Vans US Open of Surfing 2Health News:Pastry Palace of Las Vegas Announces It Is Now Offering Custom Wedding Cakes in Las Vegas 2
(Date:7/13/2015)... Jul. 13, 2015 NXT-ID, Inc. (NASDAQ: ... authentication company focused on the growing mobile commerce ... patent 62/188684 for BEHAVIORAL-DIRECTED AUTHENTIATION METHOD ... convenient and secure method to make payments.  With ... methods, introduced with its groundbreaking voice-direct payment patent ...
(Date:7/8/2015)... , July 8, 2015 Summary Pancreatic ... the fourth most fatal, with a mortality rate of ... prognosis of pancreatic cancer patients has highlighted a significant ... is not being met by the current market. ... of products with varying molecule types and mechanisms of ...
(Date:7/7/2015)... MOUNTAIN VIEW, Calif. , July 7, 2015 ... mobile biometrics market, Frost & Sullivan recognizes Credence ... & Sullivan Entrepreneurial Company of the Year ... product suite to aid in its mission of ... and under-recognized populations globally. As Credence ID was ...
Breaking Biology News(10 mins):NXT-ID Patents Behavior-Directed Payments 2NXT-ID Patents Behavior-Directed Payments 3NXT-ID Patents Behavior-Directed Payments 4Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 3Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 2Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 3Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 4Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 5
Other Contents